Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-18

FDA Approved: AMLODIPINE BESYLATE 2.5 MG — Supplemental Application (Oxford Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application to add a 2.5 mg strength of amlodipine besylate for Oxford Pharmaceuticals’ generic product, expanding its dosage option…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate 2.5 mg (amlodipine besylate)

Snippet

SUPPL AP for AMLODIPINE BESYLATE 2.5 MG (AMLODIPINE BESYLATE)